Menu
GWAS Study

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

Rongve A, Witoelar A, Ruiz A et al.

31065058 PubMed ID
GWAS Study Type
82963 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RA
Rongve A
WA
Witoelar A
RA
Ruiz A
AL
Athanasiu L
AC
Abdelnour C
CJ
Clarimon J
HS
Heilmann-Heimbach S
HI
Hernández I
MS
Moreno-Grau S
DR
de Rojas I
ME
Morenas-Rodríguez E
FT
Fladby T
SS
Sando SB
BG
Bråthen G
BF
Blanc F
BO
Bousiges O
LA
Lemstra AW
VS
van Steenoven I
LE
Londos E
AI
Almdahl IS
PL
Pålhaugen L
EJ
Eriksen JA
DS
Djurovic S
SE
Stordal E
SI
Saltvedt I
UI
Ulstein ID
BF
Bettella F
DR
Desikan RS
IA
Idland AV
TM
Toft M
PL
Pihlstrøm L
SJ
Snaedal J
TL
Tárraga L
BM
Boada M
LA
Lleó A
SH
Stefánsson H
SK
Stefánsson K
RA
Ramírez A
AD
Aarsland D
AO
Andreassen OA
Chapter II

Abstract

Summary of the research findings

Dementia with Lewy Bodies (DLB) is a common neurodegenerative disorder with poor prognosis and mainly unknown pathophysiology. Heritability estimates exceed 30% but few genetic risk variants have been identified. Here we investigated common genetic variants associated with DLB in a large European multisite sample. We performed a genome wide association study in Norwegian and European cohorts of 720 DLB cases and 6490 controls and included 19 top-associated single-nucleotide polymorphisms in an additional cohort of 108 DLB cases and 75545 controls from Iceland. Overall the study included 828 DLB cases and 82035 controls. Variants in the ASH1L/GBA (Chr1q22) and APOE ε4 (Chr19) loci were associated with DLB surpassing the genome-wide significance threshold (p < 5 × 10-8). One additional genetic locus previously linked to psychosis in Alzheimer's disease, ZFPM1 (Chr16q24.2), showed suggestive association with DLB at p-value < 1 × 10-6. We report two susceptibility loci for DLB at genome-wide significance, providing insight into etiological factors. These findings highlight the complex relationship between the genetic architecture of DLB and other neurodegenerative disorders.

720 European ancestry cases, 6,490 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

82963
Total Participants
GWAS
Study Type
Yes
Replicated
108 European ancestry cases, 75,545 European ancestry controls
Replication Participants
European
Ancestry
Iceland, France, Netherlands, Norway, Sweden, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.